1. Home
  2. DGLY vs ATXI Comparison

DGLY vs ATXI Comparison

Compare DGLY & ATXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DGLY
  • ATXI
  • Stock Information
  • Founded
  • DGLY 2004
  • ATXI 2015
  • Country
  • DGLY United States
  • ATXI United States
  • Employees
  • DGLY N/A
  • ATXI N/A
  • Industry
  • DGLY Radio And Television Broadcasting And Communications Equipment
  • ATXI Biotechnology: Pharmaceutical Preparations
  • Sector
  • DGLY Technology
  • ATXI Health Care
  • Exchange
  • DGLY Nasdaq
  • ATXI Nasdaq
  • Market Cap
  • DGLY 3.5M
  • ATXI 2.9M
  • IPO Year
  • DGLY N/A
  • ATXI 2017
  • Fundamental
  • Price
  • DGLY $0.98
  • ATXI $1.99
  • Analyst Decision
  • DGLY
  • ATXI Strong Buy
  • Analyst Count
  • DGLY 0
  • ATXI 1
  • Target Price
  • DGLY N/A
  • ATXI $56.25
  • AVG Volume (30 Days)
  • DGLY 49.9K
  • ATXI 32.2K
  • Earning Date
  • DGLY 11-12-2024
  • ATXI 11-11-2024
  • Dividend Yield
  • DGLY N/A
  • ATXI N/A
  • EPS Growth
  • DGLY N/A
  • ATXI N/A
  • EPS
  • DGLY N/A
  • ATXI N/A
  • Revenue
  • DGLY $23,417,110.00
  • ATXI N/A
  • Revenue This Year
  • DGLY $22.14
  • ATXI N/A
  • Revenue Next Year
  • DGLY N/A
  • ATXI N/A
  • P/E Ratio
  • DGLY N/A
  • ATXI N/A
  • Revenue Growth
  • DGLY N/A
  • ATXI N/A
  • 52 Week Low
  • DGLY $0.84
  • ATXI $1.71
  • 52 Week High
  • DGLY $3.29
  • ATXI $45.00
  • Technical
  • Relative Strength Index (RSI)
  • DGLY 40.77
  • ATXI 34.34
  • Support Level
  • DGLY $1.00
  • ATXI $1.89
  • Resistance Level
  • DGLY $1.17
  • ATXI $2.10
  • Average True Range (ATR)
  • DGLY 0.06
  • ATXI 0.21
  • MACD
  • DGLY 0.01
  • ATXI 0.00
  • Stochastic Oscillator
  • DGLY 11.77
  • ATXI 33.33

About DGLY Digital Ally Inc.

Digital Ally Inc produces digital video imaging and storage products for use in law enforcement, security, and commercial applications. Its products are an in-car digital video/audio recorder contained in a rear-view mirror for use in law enforcement and commercial fleets. It can integrate electronic, radio, computer, and multi-media technologies to create solutions to address needs in a variety of other industries and markets, including mass transit, school buses, taxicab, and military. The company sells its products directly to law enforcement agencies, security organizations, and consumer and commercial fleet operators both domestically and internationally through third-party distributors. Its segments include Video Solutions, Revenue Cycle Management, and Entertainment.

About ATXI Avenue Therapeutics Inc.

Avenue Therapeutics Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of rare and neurologic diseases. It focuses on developing its product candidate, AJ201, for spinal and bulbar muscular atrophy, BAER-101, for the treatment of epilepsy and panic disorders, and IV Tramadol for the management of moderate-to-moderately-severe pain in adults.

Share on Social Networks: